Algerian Pharmaceutical Industry: Prospective Structural Analysis Using MICMAC Method
Abstract
This work aims to determine the key variables that control the development of the Algerian pharmaceutical industry in the long term using structural analysis by MICMAC method. After listing the variables, filling in the matrix of direct influences, and analyzing the indirect potential plan we select the key variables, which are Research and Development, Consumption, innovation, the level of production, production costs, and marketing/sales. We can add other regulatory variables such as human capital, partnership with foreign countries, research costs, prices, and investment.
Downloads
References
Barbosa, D. M., Ayala, A., & Sandoval, A. (2016). The Colombian pharmaceutical industry : Factors affecting export. European Journal of Management and Business Economics, 25(2), 39‑46. https://doi.org/10.1016/j.redee.2015.10.004
BARTOLI, F. (2001). Système national d’innovation : Caractéristiques et perspectives pour les industries de santé en France. Education et formations, 59, 99‑112.
Chine, L., & BALOULI, H. E. (2017). Agricultural entrepreneurship in Algeria Prospective Structural analysis using MICMAC method. MÂAREF, 12(23), 65‑80.
Cockburn, I. M. (2004). The Changing Structure Of The Pharmaceutical Industry. Health Affairs, 23(1), 10‑22. https://doi.org/10.1377/hlthaff.23.1.10
de Mesa, E. G., & Muñoz, E. (2007). Foresight on biopharmaceuticals : Designing foresight methods for Spanish biopharmaceuticals. Technological Forecasting and Social Change, 74(3), 281‑297. https://doi.org/10.1016/j.techfore.2005.11.002
Foster, B. C. (2008). Foresight Scanning : Future Directions of Clinical and Pharmaceutical Research. Journal of Pharmacy & Pharmaceutical Sciences, 11(4), 108s‑122s. https://doi.org/10.18433/J3NK5M
Godet, M. (1986). Introduction to la prospective : Seven key ideas and one scenario method. Futures, 18(2), 134‑157. https://doi.org/10.1016/0016-3287(86)90094-7
Godet, M. (2000). The Art of Scenarios and Strategic Planning : Tools and Pitfalls. Technological Forecasting and Social Change, 65(1), 3‑22. https://doi.org/10.1016/S0040-1625(99)00120-1
Kisa, A. (2006). Analysis of the pharmaceuticals market and its technological development in Turkey. International Journal of Technology Assessment in Health Care, 22(4), 537‑542. https://doi.org/10.1017/S026646230605149X
Lintonen, T., Konu, A., Rönkä, S., & Kotovirta, E. (2014). Drugs foresight 2020 : A Delphi expert panel study. Substance Abuse Treatment, Prevention, and Policy, 9(1), 18. https://doi.org/10.1186/1747-597X-9-18
Nadira, B., & Amina, B. (2017). L’Industrie Pharmaceutique en Algérie—Vecteur de Croissance Socioéconomique. Al Moasher Journal for Economic Studies, 1(4), 272‑289.
Ragan, I. (2007). Drugs Futures 2025? Perspective of the Pharmaceutical Industry. Drugs and the Future, 507‑533. https://doi.org/10.1016/B978-012370624-9/50021-9
Ziani, L. (2021). L’industrie du médicament en Algérie : Etat des lieux et contraintes. Abaad Iktissadia review, 11(1), 419‑443.
Copyright (c) 2022 BALOULI Houssame Eddine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
